Subtypes of breast cancer show preferential site of relapse.
about
Understanding and treating triple-negative breast cancerUptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancerLatent bone metastasis in breast cancer tied to Src-dependent survival signalsAnalyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosisVitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trialBreast cancer intrinsic subtype classification, clinical use and future trendsBiomarkers in triple negative breast cancer: A reviewTargeting triple-negative breast cancer: optimising therapeutic outcomesActivation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumorsTargeted Therapies for Brain Metastases from Breast CancerImplications of Hypoxia in Breast Cancer Metastasis to BoneBreast cancer brain metastases: biology and new clinical perspectivesMechanisms involved in breast cancer liver metastasisProgesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexesSystems level analysis and identification of pathways and networks associated with liver fibrosisImpact of molecular subtypes on metastatic breast cancer patients: a SEER population-based studyBreast carcinomas: variations in sonoelastographic appearance.A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genesWnt signaling in triple negative breast cancer is associated with metastasisNCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression DataTesting for association between RNA-Seq and high-dimensional dataDetection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.Biomarker profile in breast carcinomas presenting with bone metastasis.Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungsEpithelial to mesenchymal transition and breast cancer.Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapiesExtracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro.AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.Breast cancer subtypes predict the preferential site of distant metastases: a SEER based studyApplication of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinomaBreast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition?High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Specific genomic aberrations in primary colorectal cancer are associated with liver metastasesAssociation between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancerLoss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer.Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.A pathway-based classification of human breast cancer.
P2860
Q24620957-4FCC78E2-D81F-4E5D-A9D7-0BD6336FBB67Q24621947-3844E9EB-8178-4782-889A-8CFD368003E5Q24648828-8FBB8484-8139-4EC5-A31E-70AFB6A4F7D7Q24651212-8F1F0518-AD38-497F-9283-0A29526C3AEAQ24652763-10E44FCD-6062-4D8A-8DED-5E6AD5217F71Q26773761-56876756-9193-48BB-ACDD-DA348424718AQ26775094-C63AF62E-88C5-44ED-A394-073BC7894265Q26850892-4328FDC5-E173-4235-82C1-4BB876F6DC3FQ27437626-362556EB-B63A-4DB0-A10E-2DDA3B00E1CDQ28068154-69E53F30-5C10-451B-A781-7156EDAFF9B6Q28077444-E7E56DB6-8DA1-494A-BA80-14431205C7DAQ28078998-DF4E01AA-8912-4363-812B-6BE963ED22E7Q28084024-15814EE4-7671-4071-80A7-709C51E7692DQ28306753-B81B671B-086C-4D61-8231-873B7EB2DBB7Q28544814-850234E9-E88D-4E77-AA60-369774C39751Q29248323-8992981D-E590-41A4-9E9C-93C6A39E2CFAQ30432189-C99EE219-2D6A-4BFD-9D3D-E8C76700FA7DQ30566202-B3EB580C-CF1A-450C-BC20-B9A4A1AFD0C9Q30597238-F6A528BA-F43C-4382-BA28-416FA52D9B0DQ30975484-DDF90EC8-6881-4839-B67C-D3045DCAFFBEQ31030029-2C1B950B-3570-4F34-85B1-212C8A12864EQ31054019-83C87A4C-6CA0-4950-9E4E-003E30A7C68FQ33551239-1BBD6E27-2579-4EC3-8AAB-58F3FF0FE381Q33604642-E15067D2-68DB-41CC-8B99-045FC39ED5EDQ33609142-D5C7DC5D-C0D2-4D86-B994-1FE33262D036Q33627118-8921535F-03DA-4AC9-9547-D45BB0EDC841Q33628894-C16D04F7-F151-4C29-AC7C-2D67573B40E5Q33634352-18C5005D-1A21-4B92-8091-EEDAEF195642Q33667940-1C03B5AD-F9C0-434D-8B9E-2327E406ED85Q33709532-0E744B0A-057A-4AAF-9B49-6059A4FD7EA1Q33715938-50EB3D8A-FD86-42D2-9CE9-2FA84254E95AQ33738679-60F65526-70BE-4E2F-B393-CFAF9EB8AF6DQ33739228-F1806EC8-873D-47E7-82F2-BF2EBCD4EE0DQ33739253-140A1AC3-43EA-458C-B481-C0EE8B900BFAQ33751806-81782966-B5CE-420D-92DD-DBD5D94BA099Q33761768-1453BD79-480C-4233-8FDA-E80445CD41B9Q33770092-ADE74199-8D39-4517-853F-B6A037FA08D8Q33814282-C2D70B08-D3BB-44C9-AA02-CD70DC8AFF93Q33814357-7525DE3F-59DF-49FF-A3E0-425AD806C64AQ33859531-1B19A98D-0182-4565-95CA-C692ACD55A06
P2860
Subtypes of breast cancer show preferential site of relapse.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Subtypes of breast cancer show preferential site of relapse.
@en
Subtypes of breast cancer show preferential site of relapse.
@nl
type
label
Subtypes of breast cancer show preferential site of relapse.
@en
Subtypes of breast cancer show preferential site of relapse.
@nl
prefLabel
Subtypes of breast cancer show preferential site of relapse.
@en
Subtypes of breast cancer show preferential site of relapse.
@nl
P2093
P1433
P1476
Subtypes of breast cancer show preferential site of relapse.
@en
P2093
Anieta M Sieuwerts
Jan G M Klijn
John A Foekens
John W M Martens
Marcel Smid
Yixin Wang
P304
P356
10.1158/0008-5472.CAN-07-5644
P407
P577
2008-05-01T00:00:00Z